Paper38889481
Tumour-specific activation of a tumour-blood transport improves the diagnostic accuracy of blood tumour markers in mice.
Schmithals C and 18 others. EBioMedicine, 2024. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Tumour-specific activation of a tumour-blood transport improves the diagnostic accuracy of blood tumour markers in mice. Papers, record 38889481. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38889481
- Cell line
- Hep-G2496 papers
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Tumour-specific activation of a tumour-blood transport improves the diagnostic accuracy of blood tumour markers in mice.
- PubMed
Connected records3
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biomarkers, Tumor | Major topic |
| Phosphoric Diester Hydrolases | Major topic |
| Carcinoma, Hepatocellular | Major topic |
| Disease Models, Animal | Major topic |
| Liver Neoplasms | Major topic |
| Animals | |
| Mice | |
| alpha-Fetoproteins | |
| Male | |
| Humans | |
| Cell Line, Tumor | |
| Prostatic Neoplasms | |
| Oligopeptides | |
| Lysophospholipase D |
Source PubMed
References54
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18363553 | Neuropilins: structure, function and role in disease. | Biochem J | 2008 | https://conductscience.org/library/papers/18363553 | PubMed |
| 2 | 29753567 | Junctional adhesion molecules JAM-B and JAM-C promote autoimmune-mediated liver fibrosis in mice. | J Autoimmun | 2018 | https://conductscience.org/library/papers/29753567 | PubMed |
| 3 | 22745587 | Reduced efficacy of the Plk1 inhibitor BI 2536 on the progression of hepatocellular carcinoma due to low intratumoral drug levels. | Neoplasia | 2012 | https://conductscience.org/library/papers/22745587 | PubMed |
| 4 | 35803295 | CEND-1: a game changer for pancreatic cancer chemotherapy? | Lancet Gastroenterol Hepatol | 2022 | https://conductscience.org/library/papers/35803295 | PubMed |
| 5 | 35676420 | Circulating biomarkers in the diagnosis and management of hepatocellular carcinoma. | Nat Rev Gastroenterol Hepatol | 2022 | https://conductscience.org/library/papers/35676420 | PubMed |
| 6 | 33986122 | Bifunctional iRGD-anti-CD3 enhances antitumor potency of T cells by facilitating tumor infiltration and T-cell activation. | J Immunother Cancer | 2021 | https://conductscience.org/library/papers/33986122 | PubMed |
| 7 | 12143051 | Expression, regulation, and function of alpha V integrins in hepatocellular carcinoma: an in vivo and in vitro study. | Hepatology | 2002 | https://conductscience.org/library/papers/12143051 | PubMed |
| 8 | 19962669 | Tissue-penetrating delivery of compounds and nanoparticles into tumors. | Cancer Cell | 2009 | https://conductscience.org/library/papers/19962669 | PubMed |
| 9 | 1707140 | Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. | N Engl J Med | 1991 | https://conductscience.org/library/papers/1707140 | PubMed |
| 10 | 37315449 | A comprehensive evaluation of full-spectrum cell-free RNAs highlights cell-free RNA fragments for early-stage hepatocellular carcinoma detection. | EBioMedicine | 2023 | https://conductscience.org/library/papers/37315449 | PubMed |
| 11 | 26239478 | Improving Drug Penetrability with iRGD Leverages the Therapeutic Response to Sorafenib and Doxorubicin in Hepatocellular Carcinoma. | Cancer Res | 2015 | https://conductscience.org/library/papers/26239478 | PubMed |
| 12 | 8642308 | Vesiculo-vacuolar organelles and the regulation of venule permeability to macromolecules by vascular permeability factor, histamine, and serotonin. | J Exp Med | 1996 | https://conductscience.org/library/papers/8642308 | PubMed |
| 13 | 20378772 | Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs. | Science | 2010 | https://conductscience.org/library/papers/20378772 | PubMed |
| 14 | 12514785 | Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma. | Hum Pathol | 2002 | https://conductscience.org/library/papers/12514785 | PubMed |
| 15 | 18474629 | Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection. | J Exp Med | 2008 | https://conductscience.org/library/papers/18474629 | PubMed |
| 16 | 28167508 | Hypoxia Causes Downregulation of Dicer in Hepatocellular Carcinoma, Which Is Required for Upregulation of Hypoxia-Inducible Factor 1α and Epithelial-Mesenchymal Transition. | Clin Cancer Res | 2017 | https://conductscience.org/library/papers/28167508 | PubMed |
| 17 | 28414297 | Tumor-penetrating peptide enhances transcytosis of silicasome-based chemotherapy for pancreatic cancer. | J Clin Invest | 2017 | https://conductscience.org/library/papers/28414297 | PubMed |
| 18 | 16177780 | Pathophysiological consequences of VEGF-induced vascular permeability. | Nature | 2005 | https://conductscience.org/library/papers/16177780 | PubMed |
| 19 | 33538338 | Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. | CA Cancer J Clin | 2021 | https://conductscience.org/library/papers/33538338 | PubMed |
| 20 | 33947161 | Neuropilin 1 Regulation of Vascular Permeability Signaling. | Biomolecules | 2021 | https://conductscience.org/library/papers/33947161 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42983536 | Metabolic-extracellular matrix crosstalk in hepatocellular carcinoma: mechanisms and targeted intervention. | Cell Commun Signal | 2026 | https://conductscience.org/library/papers/42983536 | PubMed |
| 41704422 | Co-administered internalizing RGD peptide boosts anti-PD-L1 therapy in hepatocellular carcinoma. | JHEP Rep | 2026 | https://conductscience.org/library/papers/41704422 | PubMed |
| 39931738 | Vascular endothelial cell injury: causes, molecular mechanisms, and treatments. | MedComm (2020) | 2025 | https://conductscience.org/library/papers/39931738 | PubMed |
| 39789733 | Population Pharmacokinetic Modeling of Certepetide in Human Subjects With Metastatic Pancreatic Ductal Adenocarcinoma. | Clin Pharmacol Drug Dev | 2025 | https://conductscience.org/library/papers/39789733 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38889481
GET https://conductscience.org/api/papers/v1/38889481/references?page=2